stella
beta
Durvalumab as Consolidation for Patients LS-SCLC — Stella
Recruiting
Back to Small Cell Lung Cancer Limited Stage trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
China
The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei
View full record on ClinicalTrials.gov